Related Experiment Video
Updated: Jan 17, 2026

Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts
Published on: September 20, 2024
Deep phenotyping of heart failure with preserved ejection fraction through multi-omics integration
Jakob Versnjak1,2, Titus Kuehne1,2,3,4, Pauline Fahjen5
1Institute of Computer-assisted Cardiovascular Medicine, Deutsches Herzzentrum der Charité, Berlin, Germany.
This study developed a machine learning model to identify heart failure with preserved ejection fraction (HFpEF) phenotypes years before symptom onset. Early detection through multi-omics data enables personalized preventive strategies for this complex cardiovascular condition.
Area of Science:
- Cardiology
- Genomics
- Computational Biology
Background:
- Heart failure with preserved ejection fraction (HFpEF) is the most common type of heart failure, posing significant challenges due to its heterogeneous nature and limited treatment options.
- Early identification of HFpEF is critical for implementing effective preventive strategies, especially considering its association with lifestyle-related comorbidities.
Purpose of the Study:
- To introduce and validate a machine learning-based multi-omics approach for early detection and characterization of HFpEF.
- To integrate clinical and molecular data for improved diagnostic and prognostic capabilities in HFpEF.
Main Methods:
- A supervised classifier was trained on a large UK Biobank cohort (n=401,917) using phenotypic profiles.
- Model performance was validated in an independent hold-out set (n=100,946) including individuals with and without HFpEF.
- Similarity Network Fusion (SNF) was employed to identify distinct HFpEF subgroups based on multi-omics data.
Main Results:
- The classifier achieved high accuracy in identifying HFpEF phenotypes, with an ROC AUC of 0.931.
- The model detected individuals who later developed HFpEF an average of 6.3 years prior to symptom onset.
- A high-risk HFpEF subgroup with elevated mortality and inflammatory pathway dysregulation was identified with an ROC AUC of 0.988.
Conclusions:
- The study successfully identified HFpEF phenotypes at an early, potentially modifiable stage, years before clinical manifestation.
- The multi-omics approach provides novel insights into HFpEF complexity and enables more precise risk stratification.
- Early detection and characterization are key to improving preventive strategies and patient outcomes for HFpEF.
Related Concept Videos
Heart Failure II: Pathophysiology
Pathophysiology of Heart Failure
Heart Failure I: Introduction
Heart Failure IV: Classification and Diagnostic Evaluation
Heart Failure III: Clinical Manifestations
Cardiomyopathy III: Hypertrophic Cardiomyopathy

